The federal bill aims to improve access to prescription drug information for visually impaired patients by requiring pharmaceutical manufacturers to provide accessible prescription drug label information, including dosage instructions and warnings, in formats that can be easily read or heard by individuals with visual impairments. This includes implementing technologies like radio frequency identification (RFID) tags or other accessible labeling methods. The bill intends to enhance medication safety and independence for visually impaired individuals when managing their prescriptions.
2024-01-18: Introduced
2024-02-06: Referred to committee: Insurance
Contribute Your Insights: Add a Unique Perspective to Political Bills. Your Contribution will be Featured Below the Primary Bill, Ordered by Date Added.
No Reviews found ..